Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07611552
What this trial is testing

Effects of Inulin on Cardiometabolic Risk Factors in Individuals Using Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA ) Medications for Weight Loss

Who this might be right for
Obesity & Overweight
Huazhong University of Science and Technology 600
Not applicableEnded earlyNCT01303315
What this trial is testing

TANTALUS Therapy in Type 2 Diabetic Patients Intolerant or Inadequately Responsive to GLP-1 Receptor Agonist Therapy

Who this might be right for
Diabetes Mellitus, Type 2
MetaCure (USA), Inc. 20
Testing effectiveness (Phase 2)Study completedNCT06282458
What this trial is testing

Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight Mgmt

Who this might be right for
Muscle LossObesity
Veru Inc. 168
Testing effectiveness (Phase 2)Study completedNCT02770885
What this trial is testing

Effects of GLP-1 Analogues on Fluid Intake in Patients With Primary Polydipsia (The GOLD-Study)

Who this might be right for
Primary Polydipsia
University Hospital, Basel, Switzerland 50
Testing effectiveness (Phase 2)Study completedNCT01200940
What this trial is testing

Metabolic Effects of Non-Nutritive Sweeteners

Who this might be right for
Healthy Volunteers
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 118
Not applicableStudy completedNCT03081676
What this trial is testing

The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea

Who this might be right for
Maturity-Onset Diabetes of the Young, Type 3
University Hospital, Gentofte, Copenhagen 20
Large-scale testing (Phase 3)Study completedNCT03730662
What this trial is testing

Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk

Who this might be right for
Type 2 Diabetes Mellitus
Eli Lilly and Company 2,002
Not applicableLooking for participantsNCT07702461
What this trial is testing

Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists

Who this might be right for
Obesity & OverweightDiabetes (DM)
Ohio State University 300
Not applicableUnknownNCT04383197
What this trial is testing

Exercise and GLP-1 RA on Insulin Secretion

Who this might be right for
Type 2 Diabetes
University of Copenhagen 30
Not applicableUnknownNCT04733508
What this trial is testing

Glucagon Like Peptide 1 Receptor (GLP1R) Expression and Beta-cell Mass in Patients With Type 2 Diabetes

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 2
Radboud University Medical Center 28
Not applicableStudy completedNCT00776243
What this trial is testing

Short-term Effect of Intensive Insulin Therapy on Incretin Secretion

Who this might be right for
Type 2 Diabetes
The Catholic University of Korea 30
Early research (Phase 1)Study completedNCT02163278
What this trial is testing

A Multiple Ascending Dose Phase I Study of DBPR108 in Healthy Male Subjects

Who this might be right for
Diabetes Mellitus, Type 2
National Health Research Institutes, Taiwan 32
Not applicableLooking for participantsNCT07244458
What this trial is testing

Dietary Peanuts and Nutrition-Related Outcomes

Who this might be right for
Dietary ChangeObesity & OverweightFood Acceptance
Ian J. Neeland, MD 64
Post-approval studies (Phase 4)UnknownNCT02503943
What this trial is testing

Effects of Incretin on the Blood Pressure and Lipid in Patients With Overweight or Obese Diabetes

Who this might be right for
Type 2 DiabetesOverweightObesity+1 more
Third Affiliated Hospital of Third Military Medical University 90
Early research (Phase 1)Study completedNCT00013910
What this trial is testing

NNC 90-1170 Mechanism of Action: A Double-Blind, Randomized, Single-Center, Placebo-Controlled, Crossover Study to Examine Beta-Cell Responsiveness to Graded Glucose Infusion in Subjects With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Non-Insulin-Dependent
National Center for Research Resources (NCRR) 30
Not applicableStudy completedNCT01460069
What this trial is testing

The Effect of Glucagon Like Peptide (GLP)-1 in Psoriasis

Who this might be right for
Psoriasis
Annesofie Faurschou 20
Post-approval studies (Phase 4)Study completedNCT02180334
What this trial is testing

The Effect of Combination of Mosapride and DPP-4 Inhibitor on Plasma Concentration of Incretin Hormones

Who this might be right for
Diabetes Mellitus, Type 2
Seoul National University Hospital 12
Large-scale testing (Phase 3)Looking for participantsNCT07575399
What this trial is testing

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Who this might be right for
Obesity or Overweight
Amgen 300
Large-scale testing (Phase 3)Study completedNCT03954834
What this trial is testing

Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone

Who this might be right for
Type 2 Diabetes Mellitus
Eli Lilly and Company 478
Testing effectiveness (Phase 2)WithdrawnNCT03371862
What this trial is testing

Liraglutide on Decreasing Parenteral Support in Short Bowel Patients (SLIPS)

Who this might be right for
Short Bowel Syndrome
Imperial College London
Next Page